ODYSSEY (Completed)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of SAR236553/REGN727 on the Occurrence of Cardiovascular Events in Patients who have Recently Experienced an Acute Coronary Syndrome.
- Medicine
- alirocumab
- Population
- ASCVD
- Phase
- IIIb
- Starting year
- 2012
- More information
- ClinicalTrials.gov